These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 11920221

  • 1. HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand.
    Gillespie G, Mutis T, Schrama E, Kamp J, Esendam B, Falkenburg JF, Goulmy E, Moss P.
    Hematol J; 2000; 1(6):403-10. PubMed ID: 11920221
    [Abstract] [Full Text] [Related]

  • 2. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
    Mutis T, Blokland E, Kester M, Schrama E, Goulmy E.
    Blood; 2002 Jul 15; 100(2):547-52. PubMed ID: 12091347
    [Abstract] [Full Text] [Related]

  • 3. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.
    Mutis T, Verdijk R, Schrama E, Esendam B, Brand A, Goulmy E.
    Blood; 1999 Apr 01; 93(7):2336-41. PubMed ID: 10090944
    [Abstract] [Full Text] [Related]

  • 4. Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
    Mutis T, Ghoreschi K, Schrama E, Kamp J, Heemskerk M, Falkenburg JH, Wilke M, Goulmy E.
    Biol Blood Marrow Transplant; 2002 Apr 01; 8(8):412-9. PubMed ID: 12234166
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exclusive TCRVbeta chain usage of ex vivo generated minor Histocompatibility antigen HA-1 specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping.
    Verdijk RM, Mutis T, Wilke M, Pool J, Schrama E, Brand A, Goulmy E.
    Hematol J; 2002 Apr 01; 3(6):271-5. PubMed ID: 12522448
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of a graft versus host disease-associated human minor histocompatibility antigen.
    den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH.
    Science; 1995 Jun 09; 268(5216):1476-80. PubMed ID: 7539551
    [Abstract] [Full Text] [Related]

  • 10. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.
    Kloosterboer FM, van Luxemburg-Heijs SA, van Soest RA, Barbui AM, van Egmond HM, Strijbosch MP, Kester MG, Marijt WA, Goulmy E, Willemze R, Falkenburg JH.
    Leukemia; 2004 Apr 09; 18(4):798-808. PubMed ID: 14973499
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
    Schilbach K, Kerst G, Walter S, Eyrich M, Wernet D, Handgretinger R, Xie W, Rammensee HG, Müller I, Bühring HJ, Niethammer D.
    Blood; 2005 Jul 01; 106(1):144-9. PubMed ID: 15731181
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1.
    Mommaas B, Stegehuis-Kamp JA, van Halteren AG, Kester M, Enczmann J, Wernet P, Kögler G, Mutis T, Brand A, Goulmy E.
    Blood; 2005 Feb 15; 105(4):1823-7. PubMed ID: 15498856
    [Abstract] [Full Text] [Related]

  • 14. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.
    Heemskerk MH, Hoogeboom M, de Paus RA, Kester MG, van der Hoorn MA, Goulmy E, Willemze R, Falkenburg JH.
    Blood; 2003 Nov 15; 102(10):3530-40. PubMed ID: 12869497
    [Abstract] [Full Text] [Related]

  • 15. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens.
    Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TN, Haanen JB, Mutis T, Goulmy E.
    Nat Med; 2002 Apr 15; 8(4):410-4. PubMed ID: 11927949
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Falkenburg JH, Goselink HM, van der Harst D, van Luxemburg-Heijs SA, Kooy-Winkelaar YM, Faber LM, de Kroon J, Brand A, Fibbe WE, Willemze R.
    J Exp Med; 1991 Jul 01; 174(1):27-33. PubMed ID: 2056279
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
    Warren EH, Greenberg PD, Riddell SR.
    Blood; 1998 Mar 15; 91(6):2197-207. PubMed ID: 9490709
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells.
    Eiz-Vesper B, Horn PA, Daubert C, Khattab B, Blasczyk R.
    Transfusion; 2006 Jul 15; 46(7):1210-20. PubMed ID: 16836569
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.